MRL/lpr mice develop systemic lupus erythematosus-like autoimmunity due to defective FAS-mediated apoptosis. We generated Faslpr mice deficient in EAF2, a transcription elongation-associated factor known to promote apoptosis in germinal center (GC) B cells and crucial for preventing autoimmunity. Contrary to expectations, EAF2 deficiency significantly reduced lymphadenopathy and splenomegaly, extended lifespan, and alleviated nephritis by decreasing renal immune complex deposition. Additionally, EAF2 deficiency markedly reduced accumulation of activated B cells, GC B cells, plasma cells, and the abnormal B220+CD3+ T cells in Faslpr mice. Further analysis revealed that Eaf2-/-Faslpr B cells showed hyperactivation upon various stimulations, followed by increased death. RNA sequencing of the B220+CD3+ cells revealed a downregulation in survival-promoting genes such as Bcl-2 and Akt and an upregulation of proapoptotic genes. We conclude that the combined deficiency in FAS- and EAF2-mediated apoptotic pathways leads to B cell hyperactivation and subsequent death, thereby ameliorating systemic autoimmunity in this model.
{"title":"EAF2 deficiency attenuates autoimmune disease in <i>Fas</i> <sup>lpr</sup> mice by modulating B cell activation and apoptosis.","authors":"Yingying Luan, Qing Min, Runyun Zhang, Zichao Wen, Xin Meng, Ziying Hu, Xiaoqian Feng, Meiping Yu, Lulu Dong, Ji-Yang Wang","doi":"10.1016/j.isci.2024.111220","DOIUrl":"10.1016/j.isci.2024.111220","url":null,"abstract":"<p><p>MRL/lpr mice develop systemic lupus erythematosus-like autoimmunity due to defective FAS-mediated apoptosis. We generated <i>Fas</i> <sup>lpr</sup> mice deficient in EAF2, a transcription elongation-associated factor known to promote apoptosis in germinal center (GC) B cells and crucial for preventing autoimmunity. Contrary to expectations, EAF2 deficiency significantly reduced lymphadenopathy and splenomegaly, extended lifespan, and alleviated nephritis by decreasing renal immune complex deposition. Additionally, EAF2 deficiency markedly reduced accumulation of activated B cells, GC B cells, plasma cells, and the abnormal B220<sup>+</sup>CD3<sup>+</sup> T cells in <i>Fas</i> <sup>lpr</sup> mice. Further analysis revealed that <i>Eaf2</i> <sup>-/-</sup> <i>Fas</i> <sup>lpr</sup> B cells showed hyperactivation upon various stimulations, followed by increased death. RNA sequencing of the B220<sup>+</sup>CD3<sup>+</sup> cells revealed a downregulation in survival-promoting genes such as <i>Bcl-2</i> and <i>Akt</i> and an upregulation of proapoptotic genes. We conclude that the combined deficiency in FAS- and EAF2-mediated apoptotic pathways leads to B cell hyperactivation and subsequent death, thereby ameliorating systemic autoimmunity in this model.</p>","PeriodicalId":342,"journal":{"name":"iScience","volume":"27 11","pages":"111220"},"PeriodicalIF":4.6,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11565555/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142646673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-21eCollection Date: 2024-11-15DOI: 10.1016/j.isci.2024.111228
Burcu Tepekule, Lisa Jörimann, Corinne D Schenkel, Lennart Opitz, Jasmin Tschumi, Rebekka Wolfensberger, Kathrin Neumann, Katharina Kusejko, Marius Zeeb, Lucas Boeck, Marisa Kälin, Julia Notter, Hansjakob Furrer, Matthias Hoffmann, Hans H Hirsch, Alexandra Calmy, Matthias Cavassini, Niklaus D Labhardt, Enos Bernasconi, Gabriela Oesch, Karin J Metzner, Dominique L Braun, Huldrych F Günthard, Roger D Kouyos, Fergal Duffy, Johannes Nemeth
In people with HIV-1 (PWH), Mycobacterium tuberculosis (MTB) infection poses a significant threat. While active tuberculosis (TB) accelerates immunodeficiency, the interaction between MTB and HIV-1 during asymptomatic phases remains unclear. Analysis of peripheral blood mononuclear cells (PBMC) transcriptomic profiles in PWH, with and without controlled viral loads, revealed distinct clustering in MTB-infected individuals. Functional annotation identified alterations in IL-6, TNF, and KRAS pathways. Notably, MTB-related genes displayed an inverse correlation with HIV-1 viremia, at both individual and signature score levels. These findings suggest that MTB infection in PWH induces a shift in immune system activation, inversely related to HIV-1 viral load. These results may explain the observed enhanced antiretroviral control in MTB-infected PWH. This study highlights the complex interplay between MTB and HIV-1, emphasizing the importance of understanding their interaction for managing co-infections in this population.
{"title":"Transcriptional profile of <i>Mycobacterium tuberculosis</i> infection in people living with HIV.","authors":"Burcu Tepekule, Lisa Jörimann, Corinne D Schenkel, Lennart Opitz, Jasmin Tschumi, Rebekka Wolfensberger, Kathrin Neumann, Katharina Kusejko, Marius Zeeb, Lucas Boeck, Marisa Kälin, Julia Notter, Hansjakob Furrer, Matthias Hoffmann, Hans H Hirsch, Alexandra Calmy, Matthias Cavassini, Niklaus D Labhardt, Enos Bernasconi, Gabriela Oesch, Karin J Metzner, Dominique L Braun, Huldrych F Günthard, Roger D Kouyos, Fergal Duffy, Johannes Nemeth","doi":"10.1016/j.isci.2024.111228","DOIUrl":"10.1016/j.isci.2024.111228","url":null,"abstract":"<p><p>In people with HIV-1 (PWH), <i>Mycobacterium tuberculosis</i> (MTB) infection poses a significant threat. While active tuberculosis (TB) accelerates immunodeficiency, the interaction between MTB and HIV-1 during asymptomatic phases remains unclear. Analysis of peripheral blood mononuclear cells (PBMC) transcriptomic profiles in PWH, with and without controlled viral loads, revealed distinct clustering in MTB-infected individuals. Functional annotation identified alterations in IL-6, TNF, and KRAS pathways. Notably, MTB-related genes displayed an inverse correlation with HIV-1 viremia, at both individual and signature score levels. These findings suggest that MTB infection in PWH induces a shift in immune system activation, inversely related to HIV-1 viral load. These results may explain the observed enhanced antiretroviral control in MTB-infected PWH. This study highlights the complex interplay between MTB and HIV-1, emphasizing the importance of understanding their interaction for managing co-infections in this population.</p>","PeriodicalId":342,"journal":{"name":"iScience","volume":"27 11","pages":"111228"},"PeriodicalIF":4.6,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11565417/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142646694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
MOTS-c is a mitochondrial microprotein that improves metabolism. Here, we demonstrate CK2 is a direct and functional target of MOTS-c. MOTS-c directly binds to CK2 and activates it in cell-free systems. MOTS-c administration to mice prevented skeletal muscle atrophy and enhanced muscle glucose uptake, which were blunted by suppressing CK2 activity. Interestingly, the effects of MOTS-c are tissue-specific. Systemically administered MOTS-c binds to CK2 in fat and muscle, yet stimulates CK2 activity in muscle while suppressing it in fat by differentially modifying CK2-interacting proteins. Notably, a naturally occurring MOTS-c variant, K14Q MOTS-c, has reduced binding to CK2 and does not activate it or elicit its effects. Male K14Q MOTS-c carriers exhibited a higher risk of sarcopenia and type 2 diabetes (T2D) in an age- and physical-activity-dependent manner, whereas females had an age-specific reduced risk of T2D. Altogether, these findings provide evidence that CK2 is required for MOTS-c effects.
{"title":"MOTS-c modulates skeletal muscle function by directly binding and activating CK2.","authors":"Hiroshi Kumagai, Su-Jeong Kim, Brendan Miller, Hirofumi Zempo, Kumpei Tanisawa, Toshiharu Natsume, Shin Hyung Lee, Junxiang Wan, Naphada Leelaprachakul, Michi Emma Kumagai, Ricardo Ramirez, Hemal H Mehta, Kevin Cao, Tae Jung Oh, James A Wohlschlegel, Jihui Sha, Yuichiro Nishida, Noriyuki Fuku, Shohei Dobashi, Eri Miyamoto-Mikami, Mizuki Takaragawa, Mizuho Fuku, Toshinori Yoshihara, Hisashi Naito, Ryoko Kawakami, Suguru Torii, Taishi Midorikawa, Koichiro Oka, Megumi Hara, Chiharu Iwasaka, Yosuke Yamada, Yasuki Higaki, Keitaro Tanaka, Kelvin Yen, Pinchas Cohen","doi":"10.1016/j.isci.2024.111212","DOIUrl":"10.1016/j.isci.2024.111212","url":null,"abstract":"<p><p>MOTS-c is a mitochondrial microprotein that improves metabolism. Here, we demonstrate CK2 is a direct and functional target of MOTS-c. MOTS-c directly binds to CK2 and activates it in cell-free systems. MOTS-c administration to mice prevented skeletal muscle atrophy and enhanced muscle glucose uptake, which were blunted by suppressing CK2 activity. Interestingly, the effects of MOTS-c are tissue-specific. Systemically administered MOTS-c binds to CK2 in fat and muscle, yet stimulates CK2 activity in muscle while suppressing it in fat by differentially modifying CK2-interacting proteins. Notably, a naturally occurring MOTS-c variant, K14Q MOTS-c, has reduced binding to CK2 and does not activate it or elicit its effects. Male K14Q MOTS-c carriers exhibited a higher risk of sarcopenia and type 2 diabetes (T2D) in an age- and physical-activity-dependent manner, whereas females had an age-specific reduced risk of T2D. Altogether, these findings provide evidence that CK2 is required for MOTS-c effects.</p>","PeriodicalId":342,"journal":{"name":"iScience","volume":"27 11","pages":"111212"},"PeriodicalIF":4.6,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11570452/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The cochlea contains two extracellular fluids, perilymph and endolymph. Endolymph exhibits high potential of approximately +80 to +110 mV (depending on species), which sensitizes sensory hair cells. Other properties of this unique fluid remain elusive, owing to its minuscule volume in rodent cochlea. We therefore developed a technique to collect high-purity endolymph from mouse cochleae. Comprehensive proteomic analysis of sampled endolymph using liquid chromatography with mass spectrometry identified 301 proteins, dominated by molecules engaged in immunity and proteostasis. Approximately 30% of these proteins were undetectable in our perilymph. A combination of mass spectrometry and different approaches revealed that, compared to perilymph, endolymph was enriched with α2-macroglobulin, osteopontin, apolipoprotein D, apolipoprotein E, and apolipoprotein J/clusterin. In other cells or tissues, α2-macroglobulin, apolipoprotein E, and apolipoprotein J contribute to the clearance of degraded proteins from extracellular fluid. Altogether, with the proteins described here, endolymph may play a protective role in stabilizing cochlear homeostasis.
{"title":"Protein profile of mouse endolymph suggests a role in controlling cochlear homeostasis.","authors":"Masatoshi Fukuda, Hiroki Okanishi, Daisuke Ino, Kazuya Ono, Takeru Ota, Eri Wakai, Takashi Sato, Yumi Ohta, Yoshiaki Kikkawa, Hidenori Inohara, Yoshikatsu Kanai, Hiroshi Hibino","doi":"10.1016/j.isci.2024.111214","DOIUrl":"https://doi.org/10.1016/j.isci.2024.111214","url":null,"abstract":"<p><p>The cochlea contains two extracellular fluids, perilymph and endolymph. Endolymph exhibits high potential of approximately +80 to +110 mV (depending on species), which sensitizes sensory hair cells. Other properties of this unique fluid remain elusive, owing to its minuscule volume in rodent cochlea. We therefore developed a technique to collect high-purity endolymph from mouse cochleae. Comprehensive proteomic analysis of sampled endolymph using liquid chromatography with mass spectrometry identified 301 proteins, dominated by molecules engaged in immunity and proteostasis. Approximately 30% of these proteins were undetectable in our perilymph. A combination of mass spectrometry and different approaches revealed that, compared to perilymph, endolymph was enriched with α<sub>2</sub>-macroglobulin, osteopontin, apolipoprotein D, apolipoprotein E, and apolipoprotein J/clusterin. In other cells or tissues, α<sub>2</sub>-macroglobulin, apolipoprotein E, and apolipoprotein J contribute to the clearance of degraded proteins from extracellular fluid. Altogether, with the proteins described here, endolymph may play a protective role in stabilizing cochlear homeostasis.</p>","PeriodicalId":342,"journal":{"name":"iScience","volume":"27 11","pages":"111214"},"PeriodicalIF":4.6,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11574807/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142674857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-19DOI: 10.1016/j.isci.2024.111215
Xi Luo , Zherui Pang , Jinhua Li , Minjun Anh , Byoung Soo Kim , Ge Gao
Arterial disorders such as atherosclerosis, thrombosis, and aneurysm pose significant health risks, necessitating advanced interventions. Despite progress in artificial blood vessels and animal models aimed at understanding pathogenesis and developing therapies, limitations in graft functionality and species discrepancies restrict their clinical and research utility. Addressing these issues, bioengineered arterial equivalents (AEs) with enhanced vascular functions have been developed, incorporating innovative technologies that improve clinical outcomes and enhance disease progression modeling. This review offers a comprehensive overview of recent advancements in bioengineered AEs, systematically summarizing the bioengineered technologies used to construct these AEs, and discussing their implications for clinical application and pathogenesis understanding. Highlighting current breakthroughs and future perspectives, this review aims to inform and inspire ongoing research in the field, potentially transforming vascular medicine and offering new avenues for preclinical and clinical advances.
{"title":"Bioengineered human arterial equivalent and its applications from vascular graft to in vitro disease modeling","authors":"Xi Luo , Zherui Pang , Jinhua Li , Minjun Anh , Byoung Soo Kim , Ge Gao","doi":"10.1016/j.isci.2024.111215","DOIUrl":"10.1016/j.isci.2024.111215","url":null,"abstract":"<div><div>Arterial disorders such as atherosclerosis, thrombosis, and aneurysm pose significant health risks, necessitating advanced interventions. Despite progress in artificial blood vessels and animal models aimed at understanding pathogenesis and developing therapies, limitations in graft functionality and species discrepancies restrict their clinical and research utility. Addressing these issues, bioengineered arterial equivalents (AEs) with enhanced vascular functions have been developed, incorporating innovative technologies that improve clinical outcomes and enhance disease progression modeling. This review offers a comprehensive overview of recent advancements in bioengineered AEs, systematically summarizing the bioengineered technologies used to construct these AEs, and discussing their implications for clinical application and pathogenesis understanding. Highlighting current breakthroughs and future perspectives, this review aims to inform and inspire ongoing research in the field, potentially transforming vascular medicine and offering new avenues for preclinical and clinical advances.</div></div>","PeriodicalId":342,"journal":{"name":"iScience","volume":"27 11","pages":"Article 111215"},"PeriodicalIF":4.6,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142572166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-19eCollection Date: 2024-11-15DOI: 10.1016/j.isci.2024.111198
Hélène Cecilia, Benjamin M Althouse, Sasha R Azar, Brett A Moehn, Ruimei Yun, Shannan L Rossi, Nikos Vasilakis, Kathryn A Hanley
Viruses transmitted by Aedes mosquitoes (e.g., dengue [DENV], Zika [ZIKV]) have demonstrated high potential to spill over from their ancestral, sylvatic cycles in non-human primates to establish transmission in humans. Epidemiological models require accurate knowledge of the contact structure between hosts and vectors, which is highly sensitive to any impacts of virus infection in mosquitoes or hosts on mosquito feeding behavior. Current evidence for whether these viruses affect vector behavior is mixed. Here we leveraged a study on sylvatic DENV-2 and ZIKV transmission between two species of monkey and Aedes albopictus to determine whether virus infection of either host or vector alters vector feeding behavior. Engorgement rates varied from 0% to 100%, but this was not driven by vector nor host infection, but rather by the individual host, host species, and host body temperature. This study highlights the importance of incorporating individual-level heterogeneity of vector biting in arbovirus transmission models.
{"title":"<i>Aedes albopictus</i> is not an arbovirus aficionado when feeding on cynomolgus macaques or squirrel monkeys.","authors":"Hélène Cecilia, Benjamin M Althouse, Sasha R Azar, Brett A Moehn, Ruimei Yun, Shannan L Rossi, Nikos Vasilakis, Kathryn A Hanley","doi":"10.1016/j.isci.2024.111198","DOIUrl":"10.1016/j.isci.2024.111198","url":null,"abstract":"<p><p>Viruses transmitted by <i>Aedes</i> mosquitoes (e.g., dengue [DENV], Zika [ZIKV]) have demonstrated high potential to spill over from their ancestral, sylvatic cycles in non-human primates to establish transmission in humans. Epidemiological models require accurate knowledge of the contact structure between hosts and vectors, which is highly sensitive to any impacts of virus infection in mosquitoes or hosts on mosquito feeding behavior. Current evidence for whether these viruses affect vector behavior is mixed. Here we leveraged a study on sylvatic DENV-2 and ZIKV transmission between two species of monkey and <i>Aedes albopictus</i> to determine whether virus infection of either host or vector alters vector feeding behavior. Engorgement rates varied from 0% to 100%, but this was not driven by vector nor host infection, but rather by the individual host, host species, and host body temperature. This study highlights the importance of incorporating individual-level heterogeneity of vector biting in arbovirus transmission models.</p>","PeriodicalId":342,"journal":{"name":"iScience","volume":"27 11","pages":"111198"},"PeriodicalIF":4.6,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11563999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142646668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-19eCollection Date: 2024-11-15DOI: 10.1016/j.isci.2024.111213
Ema Gusheva, Stefan Pfenninger, Johan Lilliestam
The main task of the Intergovernmental Panel on Climate Change (IPCC) is to provide comprehensive assessments of climate science. However, there are accusations of bias toward certain research fields based on limited empirical evidence. By analyzing the evidence base of Working Group 3 (WG3) reports, we show that integrated assessment modeling (IAM) research was influential in all six assessments, and overrepresented in the Summary for Policymakers (SPM). Further, we show that a small number of men working in Western Europe and the USA dominate IAM research. Thus, global climate negotiations and science may have historically prioritized mitigation solutions suggested by an unrepresentative scientific sample and missed solutions from other perspectives like those of females and non-Western cultures. However, we also show that IAM research influence decreased in AR6, implying a leveling playing field between research fields. But more effort is needed to ensure a comprehensive assessment.
{"title":"Past peak prominence: The changing role of integrated assessment modeling in the IPCC.","authors":"Ema Gusheva, Stefan Pfenninger, Johan Lilliestam","doi":"10.1016/j.isci.2024.111213","DOIUrl":"10.1016/j.isci.2024.111213","url":null,"abstract":"<p><p>The main task of the Intergovernmental Panel on Climate Change (IPCC) is to provide comprehensive assessments of climate science. However, there are accusations of bias toward certain research fields based on limited empirical evidence. By analyzing the evidence base of Working Group 3 (WG3) reports, we show that integrated assessment modeling (IAM) research was influential in all six assessments, and overrepresented in the Summary for Policymakers (SPM). Further, we show that a small number of men working in Western Europe and the USA dominate IAM research. Thus, global climate negotiations and science may have historically prioritized mitigation solutions suggested by an unrepresentative scientific sample and missed solutions from other perspectives like those of females and non-Western cultures. However, we also show that IAM research influence decreased in AR6, implying a leveling playing field between research fields. But more effort is needed to ensure a comprehensive assessment.</p>","PeriodicalId":342,"journal":{"name":"iScience","volume":"27 11","pages":"111213"},"PeriodicalIF":4.6,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11568358/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142646675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-19eCollection Date: 2024-11-15DOI: 10.1016/j.isci.2024.111211
Mohammad Erfan Zare, Atefeh Nasir Kansestani, Xuanlan Wu, Lin Zhou, Jie Lu, Jun Huang, Yanzhong Wang, Yilei Ma, Yuzhen Gao, Jun Zhang
We employed a three-step approach to evaluate serum immunoassay-based biomarkers for detecting non-small cell lung cancer (NSCLC). In the first step, we performed a systematic review and meta-analysis and implemented the Laboratory Medicine Best Practices (LMBP) method to identify potential biomarkers. From potential biomarkers, Carcinoembryonic antigen (CEA), cytokeratin 19-fragments (Cyfra 21-1), and human epididymis protein-4 (HE4) were categorized as LMBP "recommend." In the second step, we conducted matched-case-control validation on these recommended biomarkers and SAA, identified as the most accurate in the first step. In the third step, a re-meta-analysis was performed by integrating our experimental results and considering covariates. The final results revealed that HE4 emerged as the most reliable biomarker, offering balanced sensitivity and specificity, with accuracy unaffected by tumor stage, making it suitable for early diagnosis. Our findings support the inclusion of HE4 in clinical guidelines for NSCLC diagnosis, alongside well-established biomarkers such as Cyfra 21-1 and CEA.
我们采用了一种三步法来评估基于血清免疫测定的生物标记物,以检测非小细胞肺癌(NSCLC)。第一步,我们进行了系统综述和荟萃分析,并采用实验室医学最佳实践(LMBP)方法来确定潜在的生物标志物。从潜在的生物标记物中,癌胚抗原(CEA)、细胞角蛋白19-片段(Cyfra 21-1)和人类附睾蛋白-4(HE4)被归类为LMBP "推荐"。第二步,我们对这些推荐的生物标记物和在第一步中被确定为最准确的 SAA 进行了匹配病例对照验证。第三步,通过整合我们的实验结果并考虑协变量,重新进行了元分析。最终结果显示,HE4 是最可靠的生物标记物,其灵敏度和特异性达到了平衡,准确性不受肿瘤分期的影响,因此适用于早期诊断。我们的研究结果支持将 HE4 与 Cyfra 21-1 和 CEA 等成熟的生物标记物一起纳入 NSCLC 诊断的临床指南。
{"title":"Serum human epididymis Protein-4 outperforms conventional biomarkers in the early detection of non-small cell lung cancer.","authors":"Mohammad Erfan Zare, Atefeh Nasir Kansestani, Xuanlan Wu, Lin Zhou, Jie Lu, Jun Huang, Yanzhong Wang, Yilei Ma, Yuzhen Gao, Jun Zhang","doi":"10.1016/j.isci.2024.111211","DOIUrl":"https://doi.org/10.1016/j.isci.2024.111211","url":null,"abstract":"<p><p>We employed a three-step approach to evaluate serum immunoassay-based biomarkers for detecting non-small cell lung cancer (NSCLC). In the first step, we performed a systematic review and meta-analysis and implemented the Laboratory Medicine Best Practices (LMBP) method to identify potential biomarkers. From potential biomarkers, Carcinoembryonic antigen (CEA), cytokeratin 19-fragments (Cyfra 21-1), and human epididymis protein-4 (HE4) were categorized as LMBP \"recommend.\" In the second step, we conducted matched-case-control validation on these recommended biomarkers and SAA, identified as the most accurate in the first step. In the third step, a re-meta-analysis was performed by integrating our experimental results and considering covariates. The final results revealed that HE4 emerged as the most reliable biomarker, offering balanced sensitivity and specificity, with accuracy unaffected by tumor stage, making it suitable for early diagnosis. Our findings support the inclusion of HE4 in clinical guidelines for NSCLC diagnosis, alongside well-established biomarkers such as Cyfra 21-1 and CEA.</p>","PeriodicalId":342,"journal":{"name":"iScience","volume":"27 11","pages":"111211"},"PeriodicalIF":4.6,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11550588/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142611105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-18DOI: 10.1016/j.isci.2024.111194
Guangdong Liu , Cui Yang , Xin Wang , Xi Chen , Huaibin Cai , Weidong Le
Neurodegenerative diseases (NDs) are a group of neurological disorders characterized by the progressive dysfunction of neurons and glial cells, leading to their structural and functional degradation in the central and/or peripheral nervous system. Historically, research on NDs has primarily focused on the brain, brain stem, or spinal cord associated with disease-related symptoms, often overlooking the role of the cerebellum. However, an increasing body of clinical and biological evidence suggests a significant connection between the cerebellum and NDs. In several NDs, cerebellar pathology and biochemical changes may start in the early disease stages. This article provides a comprehensive update on the involvement of the cerebellum in the clinical features and pathogenesis of multiple NDs, suggesting that the cerebellum is involved in the onset and progression of NDs through various mechanisms, including specific neurodegeneration, neuroinflammation, abnormal mitochondrial function, and altered metabolism. Additionally, this review highlights the significant therapeutic potential of cerebellum-related treatments for NDs.
{"title":"Cerebellum in neurodegenerative diseases: Advances, challenges, and prospects","authors":"Guangdong Liu , Cui Yang , Xin Wang , Xi Chen , Huaibin Cai , Weidong Le","doi":"10.1016/j.isci.2024.111194","DOIUrl":"10.1016/j.isci.2024.111194","url":null,"abstract":"<div><div>Neurodegenerative diseases (NDs) are a group of neurological disorders characterized by the progressive dysfunction of neurons and glial cells, leading to their structural and functional degradation in the central and/or peripheral nervous system. Historically, research on NDs has primarily focused on the brain, brain stem, or spinal cord associated with disease-related symptoms, often overlooking the role of the cerebellum. However, an increasing body of clinical and biological evidence suggests a significant connection between the cerebellum and NDs. In several NDs, cerebellar pathology and biochemical changes may start in the early disease stages. This article provides a comprehensive update on the involvement of the cerebellum in the clinical features and pathogenesis of multiple NDs, suggesting that the cerebellum is involved in the onset and progression of NDs through various mechanisms, including specific neurodegeneration, neuroinflammation, abnormal mitochondrial function, and altered metabolism. Additionally, this review highlights the significant therapeutic potential of cerebellum-related treatments for NDs.</div></div>","PeriodicalId":342,"journal":{"name":"iScience","volume":"27 11","pages":"Article 111194"},"PeriodicalIF":4.6,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142572167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-18eCollection Date: 2024-11-15DOI: 10.1016/j.isci.2024.111207
Qixiu Du, May Nee Poon, Xiaocheng Zeng, Pengcheng Zhang, Zheng Wei, Haochen Wang, Ye Wang, Lei Wei, Xiaowo Wang
Generative design of promoters has enhanced the efficiency of de novo creation of functional sequences. Though several deep generative models have been employed in biological sequence generation, including variational autoencoder (VAE) or Wasserstein generative adversarial network (WGAN), these models might struggle with mode collapse and low sample diversity. In this study, we introduce the multinomial diffusion model (MDM) for promoter sequence design and propose a structured set of criteria for effectively comparing the performance of generative models. In silico experiments demonstrate that MDM outperforms existing generative AI approaches. MDM demonstrates superior performance in various computational evaluations, remains robust during the training process, and exhibits a strong ability in capturing weak signals. In addition, we experimentally validated that the majority of our model designed promoters have expression activities in vivo, indicating the practicality and potential of MDM for bioengineering.
{"title":"Synthetic promoter design in <i>Escherichia coli</i> based on multinomial diffusion model.","authors":"Qixiu Du, May Nee Poon, Xiaocheng Zeng, Pengcheng Zhang, Zheng Wei, Haochen Wang, Ye Wang, Lei Wei, Xiaowo Wang","doi":"10.1016/j.isci.2024.111207","DOIUrl":"https://doi.org/10.1016/j.isci.2024.111207","url":null,"abstract":"<p><p>Generative design of promoters has enhanced the efficiency of <i>de novo</i> creation of functional sequences. Though several deep generative models have been employed in biological sequence generation, including variational autoencoder (VAE) or Wasserstein generative adversarial network (WGAN), these models might struggle with mode collapse and low sample diversity. In this study, we introduce the multinomial diffusion model (MDM) for promoter sequence design and propose a structured set of criteria for effectively comparing the performance of generative models. <i>In silico</i> experiments demonstrate that MDM outperforms existing generative AI approaches. MDM demonstrates superior performance in various computational evaluations, remains robust during the training process, and exhibits a strong ability in capturing weak signals. In addition, we experimentally validated that the majority of our model designed promoters have expression activities <i>in vivo</i>, indicating the practicality and potential of MDM for bioengineering.</p>","PeriodicalId":342,"journal":{"name":"iScience","volume":"27 11","pages":"111207"},"PeriodicalIF":4.6,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11550136/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142611185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}